Score Breakdown
Offering Ability
42
Cash Runway
85
Float Risk
5
Warrant Exposure
15
Convertible Debt
40
Dilution Forecast
⛈️
Warning
High probability of dilution event
model est. 45%
🔄 Reverse Split
model est. 70%
• 50-day avg $0.58 below $1 exchange minimum
• Only 4 months cash — financial pressure
💰 Capital Raise
model 35%
• Low cash runway: 4 months remaining
Market Data
Market Cap$30.83M
Shares Outstanding62.84M
Float55.09M
Cash$4.41M
Debt$17.24M
Short InterestN/A
Institutional Holdings
QoQ: ↑ 10.1% shares (2026Q1 vs prior)
52 institutional holders · 18.72M shares
#1
AVENIR CORP
5.22M shares
#2
VANGUARD CAPITAL MANAGEMENT LLC
3.76M shares
#3
Skylands Capital, LLC
1.71M shares
+ 17 more holders Sign up free to view →
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Short Interest2.14M
Days to Cover38.3
% of Float3.9%
FINRA data as of Jul 31, 2026
Recent SEC Activity
xbrl
XBRL WARRANT
2025-12-31
xbrl
XBRL CONVERTIBLE
2016-12-31
Full SEC filing analysis available with free account →
Recent News
No recent news
Factual CTSO Dilution Snapshot
Cytosorbents Corporation (CTSO) has a DilutionScore of 50/100, rated Medium dilution risk. Score date: August 28, 2026.
- Stored outstanding warrants: 816,000.
- Recent SEC activity tracked for CTSO: xbrl on 2025-12-31; xbrl on 2016-12-31.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Related Stocks — MEDIUM Risk
Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles: